Vose JM - Search Results

1

Comparison of autologous and allogeneic hematopoietic stem cell transplantation for follicular lymphoma.

van Besien K, Loberiza FR Jr, Bajorunaite R, Armitage JO, Bashey A, Burns LJ, Freytes CO, Gibson J, Horowitz MM, Inwards DJ, Marks DI, Martino R, Maziarz RT, Molina A, Pavlovsky S, Pecora AL, Schouten HC, Shea TC, Lazarus HM, Rizzo JD, Vose JM. van Besien K, et al. Among authors: vose jm. Blood. 2003 Nov 15;102(10):3521-9. doi: 10.1182/blood-2003-04-1205. Epub 2003 Jul 31. Blood. 2003. PMID: 12893748 Free article.

2

Progressive disease after high-dose therapy and autologous transplantation for lymphoid malignancy: clinical course and patient follow-up.

Vose JM, Bierman PJ, Anderson JR, Kessinger A, Pierson J, Nelson J, Frappier B, Schmit-Pokorny K, Weisenburger DD, Armitage JO. Vose JM, et al. Blood. 1992 Oct 15;80(8):2142-8. Blood. 1992. PMID: 1356515 Free article.

3

Bone marrow transplantation for peripheral T-cell lymphoma in children and adolescents.

Gordon BG, Warkentin PI, Weisenburger DD, Vose JM, Sanger WG, Strandjord SE, Anderson JR, Verdirame JD, Bierman PJ, Armitage JO, et al. Gordon BG, et al. Among authors: vose jm. Blood. 1992 Dec 1;80(11):2938-42. Blood. 1992. PMID: 1450419 Free article.

4

High-dose cyclophosphamide, carmustine, and etoposide followed by autologous peripheral stem cell transplantation for patients with relapsed Hodgkin's disease.

Kessinger A, Bierman PJ, Vose JM, Armitage JO. Kessinger A, et al. Among authors: vose jm. Blood. 1991 Jun 1;77(11):2322-5. Blood. 1991. PMID: 1674890 Free article.

5

The use of recombinant human granulocyte-macrophage colony stimulating factor for the treatment of delayed engraftment following high dose therapy and autologous hematopoietic stem cell transplantation for lymphoid malignancies.

Vose JM, Bierman PJ, Kessinger A, Coccia PF, Anderson J, Oldham FB, Epstein C, Armitage JO. Vose JM, et al. Bone Marrow Transplant. 1991 Feb;7(2):139-43. Bone Marrow Transplant. 1991. PMID: 1675592

6

High-dose therapy and autologous peripheral stem cell transplantation for patients with bone marrow metastases and relapsed lymphoma: an alternative to bone marrow purging.

Kessinger A, Vose JM, Bierman PJ, Armitage JO. Kessinger A, et al. Among authors: vose jm. Exp Hematol. 1991 Nov;19(10):1013-6. Exp Hematol. 1991. PMID: 1680733

7

Prognostic factors in aggressive malignant lymphomas: description and validation of a prognostic index that could identify patients requiring a more intensive therapy. The Groupe d'Etudes des Lymphomes Agressifs.

Coiffier B, Gisselbrecht C, Vose JM, Tilly H, Herbrecht R, Bosly A, Armitage JO. Coiffier B, et al. Among authors: vose jm. J Clin Oncol. 1991 Feb;9(2):211-9. doi: 10.1200/JCO.1991.9.2.211. J Clin Oncol. 1991. PMID: 1703226

8

Central nervous system involvement in patients with diffuse aggressive non-Hodgkin's lymphoma.

Bashir RM, Bierman PJ, Vose JM, Weisenburger DD, Armitage JO. Bashir RM, et al. Among authors: vose jm. Am J Clin Oncol. 1991 Dec;14(6):478-82. doi: 10.1097/00000421-199112000-00004. Am J Clin Oncol. 1991. PMID: 1720278

9

Histologic grade does not predict prognosis in optimally treated, advanced-stage nodular sclerosing Hodgkin's disease.

Masih AS, Weisenburger DD, Vose JM, Bast MA, Armitage JO. Masih AS, et al. Among authors: vose jm. Cancer. 1992 Jan 1;69(1):228-32. doi: 10.1002/1097-0142(19920101)69:1<228::aid-cncr2820690137>3.0.co;2-9. Cancer. 1992. PMID: 1727667

10

Granulocyte-macrophage colony-stimulating factor (GM-CSF): answers or more questions?

Vose JM, Bierman PJ, Armitage JO. Vose JM, et al. Ann Intern Med. 1992 Feb 1;116(3):261-2. doi: 10.7326/0003-4819-116-3-261. Ann Intern Med. 1992. PMID: 1728209 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

520 results

Search Page